Jones T W, Pardon I S
Mech Ageing Dev. 1980 Nov-Dec;14(3-4):409-15. doi: 10.1016/0047-6374(80)90011-1.
Old mice show an increased sensitivity to parenteral pentobarbitone compared with young adult mice, despite similar plasma concentrations of the drug. One factor may be an alteration in the binding of barbiturate to the plasma protein, perhaps consequent on reduced hepatic synthesis of plasma protein with advancing age. As part of a study of the effect of age upon the pharmacological and adaptive response to barbiturates, binding of pentobarbitone to plasma proteins from mice of different ages was measured by equilibrium dialysis in the presence of a standard concentration of the drug. The total plasma protein concentration was measured and found to be the same in both age groups. The plasma protein binding of pentobarbitone was found to correlate significantly with the plasma albumin concentration, which was lower in the older mice. However, there was no significant overall difference in pentobarbitone binding between old and young mice. Pretreatment of the mice with phenobarbitone for 21 days had no effect upon the capacity for plasma protein binding of pentobarbitone in either age group. Thus, it seems unlikely that the increased sensitivity of older mice to pentobarbitone can be explained in terms of altered plasma protein binding of the drug.
与年轻成年小鼠相比,老年小鼠对注射用戊巴比妥的敏感性更高,尽管两种小鼠体内的药物血浆浓度相似。一个因素可能是巴比妥类药物与血浆蛋白的结合发生了改变,这可能是由于随着年龄增长肝脏合成血浆蛋白减少所致。作为研究年龄对巴比妥类药物药理和适应性反应影响的一部分,在标准浓度药物存在的情况下,通过平衡透析法测定了不同年龄小鼠血浆蛋白与戊巴比妥的结合情况。测量了总血浆蛋白浓度,发现两个年龄组的总血浆蛋白浓度相同。结果发现,戊巴比妥与血浆蛋白的结合与血浆白蛋白浓度显著相关,老年小鼠的血浆白蛋白浓度较低。然而,老年小鼠和年轻小鼠在戊巴比妥结合方面没有显著的总体差异。用苯巴比妥对小鼠进行21天的预处理,对两个年龄组中戊巴比妥与血浆蛋白结合的能力均无影响。因此,老年小鼠对戊巴比妥敏感性增加似乎不太可能用药物血浆蛋白结合改变来解释。